245 related articles for article (PubMed ID: 18974629)
21. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
[TBL] [Abstract][Full Text] [Related]
22. Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.
Hussain W; Coulson I; Owen C
Clin Exp Dermatol; 2008 Jul; 33(4):520-2. PubMed ID: 18462438
[No Abstract] [Full Text] [Related]
23. Adalimumab vs. etanercept in psoriasis.
Downs AM
Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064
[No Abstract] [Full Text] [Related]
24. Long-term management of generalized pustular psoriasis with infliximab: case series.
Routhouska SB; Sheth PB; Korman NJ
J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
[TBL] [Abstract][Full Text] [Related]
25. Superimposed linear psoriasis unmasked by therapy with adalimumab.
Arnold AW; Happle R; Itin PH
Eur J Dermatol; 2010; 20(5):573-4. PubMed ID: 20621851
[TBL] [Abstract][Full Text] [Related]
26. Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis.
Reich K; Nestle FO; Wu Y; Bala M; Eisenberg D; Guzzo C; Li S; Dooley LT; Griffiths CE
Eur J Dermatol; 2007; 17(5):381-6. PubMed ID: 17673380
[TBL] [Abstract][Full Text] [Related]
27. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
Wozel G; Vitez L
Acta Derm Venereol; 2008; 88(2):169-70. PubMed ID: 18311451
[No Abstract] [Full Text] [Related]
28. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis.
Morales-Múnera C; Vilarrasa E; Puig L
Br J Dermatol; 2013 Apr; 168(4):820-4. PubMed ID: 23210683
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases.
Pinter A; Wilsmann-Theis D; Peitsch WK; Mössner R
J Dermatol; 2019 May; 46(5):426-430. PubMed ID: 30786053
[TBL] [Abstract][Full Text] [Related]
31. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
Wozel G; Vitéz L; Meurer M
Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):133-6. PubMed ID: 18853077
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate.
Kirby B; Marsland AM; Carmichael AJ; Griffiths CE
Clin Exp Dermatol; 2001 Jan; 26(1):27-9. PubMed ID: 11260172
[TBL] [Abstract][Full Text] [Related]
33. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
[TBL] [Abstract][Full Text] [Related]
34. Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study.
Strober BE; Poulin Y; Kerdel FA; Langley RG; Gu Y; Gupta SR; Okun MM; Papp KA
J Am Acad Dermatol; 2011 Apr; 64(4):671-81. PubMed ID: 21414495
[TBL] [Abstract][Full Text] [Related]
35. Topical delivery for the treatment of psoriasis.
Mitra A; Wu Y
Expert Opin Drug Deliv; 2010 Aug; 7(8):977-92. PubMed ID: 20645673
[TBL] [Abstract][Full Text] [Related]
36. [Intermittent treatment regimens and the rational (efficient) use of biologic agents in psoriasis].
Moreno-Ramírez D
Actas Dermosifiliogr; 2011 May; 102(4):241-3. PubMed ID: 21481332
[No Abstract] [Full Text] [Related]
37. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
Nijsten T; Spuls PI
Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
[No Abstract] [Full Text] [Related]
38. [Treatment of Behçet's disease with adalimumab].
Callejas-Rubio JL; Sánchez-Cano D; Ríos-Férnandez R; Ortego-Centeno N
Med Clin (Barc); 2008 Oct; 131(11):438-9. PubMed ID: 18928730
[No Abstract] [Full Text] [Related]
39. Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockade.
Winterfield L; Menter A
Dermatol Clin; 2004 Oct; 22(4):437-47, ix. PubMed ID: 15450339
[TBL] [Abstract][Full Text] [Related]
40. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
